1. Home
  2. SCOR vs LSTA Comparison

SCOR vs LSTA Comparison

Compare SCOR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$6.62

Market Cap

112.4M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.18

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
LSTA
Founded
1999
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
28.9M
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
SCOR
LSTA
Price
$6.62
$3.18
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
9.7K
31.8K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
127.37
20.42
EPS
N/A
N/A
Revenue
$403,549,000.00
$35,283,868.00
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
$1.55
N/A
Revenue Growth
1.02
56.90
52 Week Low
$4.39
$1.81
52 Week High
$10.18
$5.07

Technical Indicators

Market Signals
Indicator
SCOR
LSTA
Relative Strength Index (RSI) 45.31 40.29
Support Level $6.22 $3.02
Resistance Level $7.07 $3.41
Average True Range (ATR) 0.38 0.12
MACD -0.05 0.05
Stochastic Oscillator 38.86 46.64

Price Performance

Historical Comparison
SCOR
LSTA

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: